Abstract. Cyclic Cushing's syndrome (CS) involves rhythmic fluctuations in ACTH secretion resulting in a cyclic variation of adrenal steroid production. In the majority of cases, cyclic CS is caused by an ACTH-secreting pituitary adenoma, but it can also be due to ectopic ACTH production or an adrenal adenoma. This condition should be strongly suspected in patients with symptoms or signs of hypercortisolism but normal cortisol levels and paradoxical responses to the dexamethasone test, that may reflect an increasing or decreasing endogenous hormone activity. Dynamic tests are best interpreted if they are performed during a sustained period of hypercortisolism. Sometimes, it is necessary to confirm the diagnosis over lengthy periods of observation. Responses to treatment must be closely monitored, interpreted and evaluated with caution because of the potential variations in steroidogenesis. An original case report of a cyclic Cushing's syndrome is presented in this review.
Introduction
Endogenous Cushing's syndrome (CS) may or may not be ACTH-dependent. The most common form of presentation (80-85% of cases) is CS caused by excessive ACTH secretion by a pituitary corticotroph adenoma. Less frequently, the ACTH secretion may be due to an extrapituitary tumor (ectopic ACTH syndrome) or, very occasionally, to a CRH-secreting tumor. ACTHindependent forms occurs in 15-20% of CS and are due to excess cortisol secretion by benign or malignant unilateral adrenocortical tumors, or by bilateral adrenal hyperplasia [1] [2] [3] [4] .
In spite of current strategies for its medical diagnosis, CS is still a challenge in clinical practice. A small subset of patients with CS have highly variable glucocorticoid secretion levels, alternating more or less regularly between normal and high values, following a clinical course with intermittent, cyclic or periodic CS.
Cyclic CS is a disorder in which rhythmic fluctuations in ACTH secretion result in a more or less predictable cyclic variation in adrenal steroid production. The timing of the fluctuations in cyclic CS can vary from a few days to several months [5, 6] and the physiopathology of this condition remains to be clarified.
Clinically, it may present with one or many symptoms. Pituitary function may be normal between cycles and paradoxical responses to dexamethasone may reflect an increasing or decreasing endogenous activity, having nothing to do with the action of the agent administered [7, 8] . Dynamic testing is best interpreted if it is performed during a sustained period of hypercortisolism. An extensive radiological and hormonal work-up is needed to detect the extrapituitary source of ACTH, though differentiating between pituitary, nonpituitary and ectopic sources of ACTH secretion may sometimes prove extremely difficult despite the wide diagnostic armamentarium available.
Difficulties in pinpointing the origin of cortisol excess may be accentuated by conditions that make it risky to attempt any invasive procedures.
Response to medical treatment must be closely monitored, because these patients may show unexpected clinical and biochemical signs of hypocortisolism. That is why the physiological mechanism underlying the cyclic nature of the CS must be carefully interpreted on the strength of the response to treatment.
The description of a case report on a patient with a variable hormone genesis offers us an opportunity to highlight the particular difficulties involved in diagnosing this complex condition
Clinical Case
A 67-year-old man was referred for evaluation for Cushing's syndrome. He had been diagnosed as having arterial hypertension and mild mitral valve insufficiency at the age of forty. He had been complaining of asthenia, changes in facial appearance, ecchymoses, muscle weakness and thin limbs for about a year. He was admitted to a cardiology unit with severe hypokalemia and a worsening mitral valve insufficiency. The mitral defect was studied hemodynamically, revealing the probable rupture of a tendinous cord and a significant coronary stenosis of the anterior interventricular branch. The hemodynamic study was complicated by a femoral artery lesion with severe bleeding.
The patient was referred to our unit. Physical examination revealed petechiae, a large hematoma in the right back, side, thigh and leg, severe myopathy and signs of cardiac failure compensated by adequate therapy (furosemide, potassium kanrenoate, ramipril and digoxin). Biochemical tests revealed hypoalbuminemia, hypokalemia (K: 2.1 mmol/L), anemia and hyperglycemia requiring insulin therapy. Endocrinological evaluation showed high urinary free cortisol (UFC) levels: 537 µg/24 h (vn: 13.7-75. 4 24 .3 and 50%, respectively). Chromogranin A levels were 1073 and 356 U/l (normal range: 19-98 U/L). POMC levels were within the normal range (8.9 pmol/L). Magnetic resonance imaging (MRI) produced a dubious image in the medial and posterior area of the pituitary gland and abdominal computed tomography (CT) showed no evidence of any adrenal lesion. Total body scintigraphy with 111 In pentreotide and PET images were negative.
The patient also had an increase in von Willebrand factor antigen (vWF: Ag): 381.7% (n: 60-160), collagen binding: 225.6% (n: 70-140) and factor VIII: 240% (n: 60-160), but without any high-molecular-weight multimers (HMWM) of vWF, so no inferior petrosal sinus catheterization was performed due to the high risk of bleeding.
Therapy was initiated with ketoconazole and a low dose was maintained (400 mg/d) because the liver enzyme levels tended to rise. While on ketoconazole treatment, the cortisol levels became normal (cortisol at 8 a.m.: 5.9 µg/dl, UFC: 25.6 µg/24 h) and insulin treatment was stopped. Clotting factors improved, but remained high and the absence of HMWM of vWF was confirmed. The myopathy was severe enough to demand at least a month of intensive physiotherapy to achieve a satisfactory evolution.
After five months of therapy, UFC levels were low, so ketoconazole therapy was stopped. After two months of ketoconazole wash out, the endocrine and hemostatic parameters were normal (cortisol was 12.9 µg/dl at 8 a.m., 3.5 µg/dl at 11 p.m., and 1.3 µg/dl after 1 mg dexamethasone; ACTH was 10 pg/ml; UFC was 10.3 and 22.0 µg/24 h on two separate occasions), except for the HMWM, which were still absent. Chromogranin levels improved (342 µg/L), as did the other hor- mone test results (FSH: 11.8 mIU/ml, LH: 4.2 mIU/ml, PRL: 18 ng/ml, testosterone: 370 ng/dl).
The patient's biochemical tests remained normal and his clinical progress was good for at least 8 months, when mitral valve replacement surgery was performed (see Fig. 1 ). He subsequently had a recurrence of Cushing's syndrome, when the UFC was 2800 µg/24h and cortisol was 80 µg/dl at 8 a.m. and 22 µg/dl at 11 p.m. Cortisol failed to respond to 1 mg (100 µg/dl) or 8 mg (69.5 µg/dl) of dexamethasone. ACTH was high (89.3 pg/ml) and a severe hypokalemia was observed (K: 1.9 mmol/L). The CRH test was positive with a 59.9% ACTH response (basal 59.2, response 94.7 pg/ml) and a 24.5% cortisol response (basal 74, response 92.2 pg/ml), but DDAVP test was negative (basal ACTH 36.3, response 51.6 pg/ml, 42%; basal cortisol 77, response 79 µg/dl, 2%). Insulin therapy was restored due to hyperglycemia. Repeat pituitary MRI showed a normal gland and abdominal CT revealed nothing new. Chest CT showed a small nodule in the apical segment of the inferior pulmonary lobe but scintigraphy with 111 In pentreotide was negative. Despite high levels of vWF, the lack of HMWM persisted. Ketoconazole therapy was started again (600 mg/d) and well tolerated. The latest endocrinological control showed: ACTH 43.1 pg/ml; cortisol 33 µg/dl at 8 a.m. and 3.8 µg/dl at 11 p.m.; UFC 20.8 µg/24 h with chromogranin A 167 U/L.
Causes and likely mechanisms implicated in the physiopathology of cyclic CS
Birke et al. [9] and then Bassoe et al. [10] described the first cases of Cushing's syndrome with fluctuations in the excretion of adrenocortical steroids. As it is seen in CS in general, cyclic CS is frequently caused by an ACTH-secreting pituitary adenoma [5] [6] [7] [8] , but it has also been reported in association with malignant carcinoid tumor of the lung [11] , oncocytic carcinoid of the kidney [12] , a bronchial adenoma [13] , ectopic ACTH production in adrenal pheochromocytoma [14] , and an adrenal adenoma [15] .
The mechanisms behind this cyclic form of CS remain unknown. A cyclic change in central dopaminergic tone has been suggested as a partial trigger for the periodic ACTH secretion [16] . Beckers et al [17] described a patient with cyclic CS following a cortisol hyperpulsatile pattern, who had a sustained response to sodium valproate treatment. Sodium valproate is known to cause an increase in gamma aminobutyric-acid (GABA), which in turn inhibits CRH secretion. These data suggested a hypothalamic origin of the disorder.
Another proposed explanation is the occurrence of spontaneous, episodic hemorrhage in the tumor resulting in temporary damage of actively secreting cells [18] , or the synchronous growth and death of ACTHsecreting tumor cells. Jordan et al. [19] suggested that a serotoninergic influence may somehow be involved in the pathogenesis of cyclic CS, since UFC was greatly reduced and the cyclic secretion contained by taking a serotonin antagonist: this hypothesis needs to be confirmed because such a response could be part of the intrinsic decrease in UFC.
We recently described a case with a bronchial carcinoid presenting as cyclic CS, initially referred to a neurosurgical unit with suspected Cushing's disease based on indirect signs (gland asymmetry and minimal stalk deviation) of a pituitary lesion on MRI. The patient had in vivo ACTH hyper-responsiveness to hexarelin and the simultaneous presence of ghrelin and both types of receptor (1a and 1b) was detected in tumoral, but not peritumoral lung tissue. After surgical removal of the tumor, the ACTH response to ghrelin disappeared. These data suggest an autocrine/paracrine modulatory effect of ghrelin on bronchial ACTH-secreting tumors [20] .
Clinical presentation and diagnosis
Clinical presentations can vary from a single, outstanding symptom, such as recurring edema, to a complex clinical syndrome. The cycles can also vary, lasting from a few hours to 85 days [5] , sometimes with long disease-free intervals [21] . Evaluation during such intervals may indicate a normal pituitary function, so the syndrome may be suspected particularly in patients with signs of CS but normal cortisol levels, or with conflicting patterns of response to dexamethasone administration. Paradoxical cortisol responses to the dexamethasone suppression test have been reported by several authors [7, 8, 11, 22] . Patients usually present with episodes of biochemical and clinical remission alternating with periods of frank Cushing's disease, characterized by circadian hyperpulsatile ACTH and cortisol secretion. Fluctuations in cortisol secretion by a tumor have been studied in depth and explain this paradoxical cortisol response to the dexamethasone suppression test. Brown et al. [7] , described a patient with Cushing's syndrome due to a pituitary adenoma, who had a paradoxical increase in cortisol after dexamethasone administration: they showed that plasma cortisol levels rose before the first dose of dexamethasone was administered, demonstrating cyclic increases and decreases in steroidogenesis. Theirs was the first accurate description of the apparently paradoxical response to dexamethasone being a purely fortuitous circumstance in a patient with a spontaneously rhythmic steroid production controlled by a mechanism not susceptible to the negative feedback action of steroids.
These findings were confirmed and expanded by Atkinson et al. [23, 24] , who described a patient with cyclic CS due to a pituitary adenoma whose cortisol and ACTH secretion followed two different rhythms, i.e. a 40-day period of cortisol excess was followed by 60-70 days of normal cortisol secretion, and during the period of excess of cortisol production, cortisol secretion peaked every 3-6 days, with intervening troughs of normal cortisol levels.
Clinicians are often obliged to hospitalize patients several times before obtaining unequivocal biological evidence of cortisol excess. Salivary cortisol measurement is an accurate method for assessing plasma free cortisol and a useful tool in the diagnosis of CS [25] , and there is a strong correlation between free plasma and salivary cortisol concentrations [26] . Saliva sample collection is simple [27, 28] and noninvasive, and it can easily be done in an outpatient setting. Repeated outpatient midnight salivary cortisol samples are a highlyeffective option for patients with cyclic CS too.
An unusual combination of Cushing's disease and corticosteroid-binding globulin (CBG) deficiency was described in a patient with periodic ACTH and cortisol secretion [29] . Biochemical assessment showed plasma free cortisol levels with low CBG concentrations, indicating that free cortisol determinations may be useful in all such particular cases.
The clinical and biochemical features of the ectopic ACTH secretion associated with carcinoid may overlap those seen in pituitary-dependent CS, making it extremely difficult to differentiate between this two entities.
Imaging is guided by biochemical assessment. MRI is the investigation of choice for Cushing's disease, but is often negative [30] . Scintigraphy with radionucleotidelabeled agonists for receptors commonly expressed by neuroendocrine tumors is used to seek occult ACTHdependent disease, sometimes with disappointing results [31] .
Despite improvements in these non-invasive tests, inferior petrosal or cavernous sinus sampling (ISS) is frequently required for the differentiation between pituitary or ectopic ACTH production. However, false negative cases have been described using ISS, and many patients presumed to have ectopic tumors on the strength of a negative inferior petrosal sinus sampling result, remain without a final diagnosis [32] .
Our patient presented with cyclic CS complicated by severe mitral valve insufficiency and an increased bleeding risk due to a lack of HMW multimers of von Willebrand factor, judged to be probably associated with the valve defect, as reported elsewhere [33] .
Our case confirms the great difficulty of locating ACTH-producing tumors and there is no single biochemical or imaging method offering an optimal accuracy. Biochemical data suggested an ectopic origin of the patient's ACTH secretion, but POMC levels were normal, and CT and total body scintigraphy with 111 In pentreotide and PET images were both negative. Valve replacement probably triggered the CS relapse. Hemostatic abnormalities persist despite valve replacement, so no inferior petrosal sinus catheterization was performed due to the high risk of bleeding.
Conclusion
Cyclic CS poses unusual diagnostic problems. The syndrome should be suspected in patients with symptoms or signs of CS but normal cortisol levels, fluctuating cortisol values, or anomalous responses to dexamethasone. Between cycles, patients may reveal a normal pituitary function so dynamic test results are best interpreted if the tests are conducted during a sustained period of hypercortisolism. Confusing results of standard 2 and 8 mg dexamethasone suppression testing suggest a spontaneous fluctuation in adrenal secretion that needs to be confirmed by extended periods of observation.
Given the possible variations in steroidogenesis, the results of drug studies in CS must be interpreted with caution.
